Mosseri Marlio Charles 4
4 · Nuvectis Pharma, Inc. · Filed Oct 29, 2025
Insider Transaction Report
Form 4
Mosseri Marlio Charles
10% Owner
Transactions
- Purchase
Common Stock
2025-10-23$6.06/sh+46,900$284,214→ 3,028,706 total(indirect: By Emerald Hill Ventures SARL SPF.) - Purchase
Common Stock
2025-10-24$6.15/sh+35,034$215,459→ 3,063,740 total(indirect: By Emerald Hill Ventures SARL SPF.) - Purchase
Common Stock
2025-10-27$6.28/sh+72,836$457,410→ 3,136,576 total(indirect: By Emerald Hill Ventures SARL SPF.)
Holdings
- 109,321
Common Stock
Footnotes (1)
- [F1]Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL SPF.